NICE Professor David Haslam explains the need for transparency in both pricing AND clinical trials. With all the information NICE could make better decisions, benefiting both the general public and the pharmaceutical industry. Read more here. (Source: Pharmafile, 4/14/28).
You are here: / / Pharma Industry – Transparency Or Public Trust – What Will It Be?